Axcellerate Pharma - Ownership and Business Overview

Life ScienceCompany

Axcellerate Pharma Ownership

Who owns Axcellerate Pharma?

Axcellerate Pharma is owned by Generic Specialties. It was acquired on May 17, 2016.

Axcellerate Pharma Business Overview

Where is Axcellerate Pharma headquartered?

Axcellerate Pharma is headquartered in Piscataway, New Jersey.

What sector is Axcellerate Pharma in?

Axcellerate Pharma is a life science company.

When was Axcellerate Pharma founded?

Axcellerate Pharma was founded in 2013.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 292 acquisitions of life science companies in 2016, including 31 acquisitions by private equity firms, and 261 by strategics.

Axcellerate Pharma LLC

20 Kingsbridge Road,
Piscataway, New Jersey 08854
United States,
(732)-853-8866
www.axcelleratepharma.com

Axcellerate Pharma LLC is a contract research organization and contract development and manufacturing organization (CRO/CDMO) focused on the development and manufacturing of sterile injectable products for generics and biologics.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.